Khartis Therapeutics
Khartis Therapeutics is a San Diego biotechnology company developing oral small-molecule medicines targeting clinically validated immunology pathways. Its lead program is an oral; selective IGF-1R inh
Funding history
About Khartis Therapeutics
How much funding has Khartis Therapeutics raised?
Khartis Therapeutics has raised $50.0M in total funding. The most recent round was Series B.
Where is Khartis Therapeutics headquartered?
Khartis Therapeutics is headquartered in San Diego, CA.
What does Khartis Therapeutics do?
Khartis Therapeutics is a San Diego biotechnology company developing oral small-molecule medicines targeting clinically validated immunology pathways. Its lead program is an oral; selective IGF-1R inh
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 9, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.